Navigation Links
Cementless cup device developed for hip replacements shows durability after more than 20 years
Date:2/2/2009

(Chicago) When a first hip replacement fails, patients may be concerned that their options for a durable hip replacement are limited and that the prognosis is poor. However, a research study to be published in the February issue of the Journal of Bone and Joint Surgery suggests that this may not be the case.

Researchers from Rush University Medical Center examined their results using one of the first cementless metal cup designs and found that fixation of the implant to bone is extremely durable even twenty years after repeat or "revision" hip replacement. The implant utilized, the Harris-Galante-1 acetabular metal shell, which is designed to allow a patient's bone to grow into the implant, remained fixed in place in 95 percent of hip revision cases at a minimum follow-up of 20 years.

The implant and its bone in-growth surface were originally developed in conjunction with Dr. Jorge Galante, an orthopedic surgeon at Rush University Medical Center and one of the present study's investigators.

The cup's porous surface allows bone and tissue to grow into the device to keep the hip implant in place. Earlier generation implants relied on the use of bone cement to secure the implant to the patient's pelvis and were associated with a higher rate of failure, particularly when used in patients who had previously had a hip implant that had failed.

"The study's results indicate that even the first generation of this device has excellent clinical results and durability," said Dr. Craig Della Valle, orthopedic surgeon at Rush and study investigator. "Even after 20 years, there is low rate of failure in terms of fixation."

Researchers previously reported the results of the use of the Harris-Galante-1 cementless acetabular shell for total hip revision procedures in 138 hips at a minimum of three, seven, and fifteen years postoperatively. The current report presents the long-term outcomes of this group at a follow-up of 20 years.

Of the original cohort of 138 hips, researchers were able to follow 73 patients who were still living (77 hips) for 20 years or more. Of the 77 hips, 37 had both clinical and radiographic evaluation, 20 had a clinical evaluation via telephone questionnaire and 21 underwent a repeat revision of the acetabular metal shell.

Twenty of the 21 cementless cups were found to be well fixed at the time of repeat revision and only one had become loose. During the entire study period, four cups were identified radiographically as being loose. For the entire cohort of 138 hips, the 20-year survivorship of the acetabular component was 95 percent.

While the long-term fixation of the device performed very well, the study did find an increased rate of repeat surgery for wear-related complications compared to the 15-year report. Ten patients, or 18 percent, had a complication related to wear of the bearing surface as opposed to 3 percent at 15 years.

"Although we have seen more complications related to wear as we have continued to follow these patients, our studies have taught us valuable lessons regarding failure mechanisms and how to avoid them," said Della Valle.

Despite the increasing prevalence of wear-related problems, the main modes of failure were infection and recurrent dislocations. The study authors recommend the use of larger diameter femoral heads and more wear-resistant bearings to decrease the risks of these complications.

"We can continue to make vast improvements in the quality of bearing and stability in the next generation of devices used in total hip replacements with the information we have gathered from this study," said Galante. "More and more patients are living longer and we must continue to further develop sustainable devices that will give patients a better quality of life."


'/>"/>

Contact: Deborah Song
deb_song@rush.edu
312-942-0588
Rush University Medical Center
Source:Eurekalert

Related medicine news :

1. MedWaves, Inc. Announces Receipt of MDD CE Certification and Additional U.S. FDA 510(k) Clearance to Market Its Patented Microwave Coagulation/Ablation System and Devices
2. New Software Technology Report for Medical Device Makers: How to Manage an FDA Controlled Software Project
3. IK4 develops a portable device for detecting Salmonella in under an hour
4. Cell transplantation and diabetes: New sites, new devices
5. Jeremy Gilbert of Syracuse University to Chair Conference on Materials for Medical Devices
6. Avalon Laboratories receives FDA and European clearances to market 3 catheter devices
7. Avalon Laboratories receives FDA and European clearances to market three catheter devices
8. Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award
9. Unbound Medicine Announces Download Support for iPhone(TM) and iPod(R) Touch Devices
10. Zassi Medical Evolutions Launches New Online Company That Uses Business DNA to Deliver Advanced Discovery, Collaboration, and Business Intelligence Tools to the Medical Device Industry
11. Gerson Lehrman Group Partners With AdvaMed for Survey on Medical Device Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: